Results 1 to 10 of about 40,108 (77)

In Vitro Microbiological Characterization of Novel Macrolide CP-163,505 for Animal Health Specific Use.

open access: yesThe Journal of Antibiotics, 1998
A novel 16-membered-ring macrolide agent (CP-163,505, a reductive amination derivative of repromicin) was identified as an antibacterial against Pasteurella haemolytica, P. multocida and Actinobacillus pleuropneumoniae, important etiological agents of livestock respiratory disease. In vitro MIC50/90 analysis revealed that CP-163,505 was more potent (4x)
L J, Norcia   +8 more
openaire   +4 more sources

In Vitro Microbiological Characterization of Novel Cyclic Homopentapeptides, CP-101,680 and CP-163,234, for Animal Health Use.

open access: yesThe Journal of Antibiotics, 1999
Two cyclic homopentapeptides, CP-101,680 and CP-163,234 [6a-(3',4'-dichlorophenylamino) analogs of viomycin and capreomycin, respectively], were identified as novel antibacterial agents for the treatment of animal disease, especially for livestock respiratory disease.
L J, Norcia   +6 more
openaire   +3 more sources
Some of the next articles are maybe not open access.

ChemInform Abstract: In vitro Microbiological Characterization of Novel Cyclic Homopentapeptides, CP‐101,680 and CP‐163,234, for Animal Health Use.

ChemInform, 2000
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
Laura J. L. Norcia   +6 more
openaire   +1 more source

Azithromyrin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study

Journal of Antimicrobial Chemotherapy, 1989
A group of 21 patients admitted to hospital with acute purulent exacerbations of chronic bronchitis was treated for five days with a new oral macrolide azithromycin. They received one dose of 500 mg on the first day, followed by 250 mg once daily thereafter. Pre-treatment sputum cultures were typical for this district, but the cultures during and after
B I, Davies, F P, Maesen, R, Gubbelmans
openaire   +2 more sources

CP-188 Intra-abdominal infections in digestive surgery wards: Is empiric antibiotic treatment in accordance with local microbiological ecology?

Clinical pharmacy, 2016
Background In 2014, new expert recommendations on treatment of intra-abdominal infections (IAI) were published. They highlighted the importance of starting empiric antibiotic therapy considering the local microbiological resistance profile and the community acquired or nosocomial character of the infection. Purpose The goal was to analyse antibiotic
M Gougeon   +6 more
openaire   +1 more source

The innate immune protein calprotectin ablates the bactericidal activity of β-lactam antibiotics. [PDF]

open access: yesProc Natl Acad Sci U S A
Velez AZ   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy